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Variables relating to diet, hormones, and genetic background are major factors in the 
development of obesity. Moreover, hypothalamic neurotransmitter systems are known 
to influence food intake, appetite, metabolism, and body weight. In particular, the 
catecholamine, norepinephrine (NE), has been shown in animals to potentiate food 
intake in satiated subjects, enhance appetite specifically for carbohydrate, affect cir- 
culating hormones and nutrients, and reduce energy expenditure. This neurotrans- 
mitter, which produces hyperphagia and increased body weight gain with chronic ad- 
ministration, is found to act via a,-noradTenergic receptors specifically in the hypothalamic 
paraventricular nucleus (PVN). Circulating substances, such as the glucocorticoid hor- 
mone corticosterone (CORT) and glucose, have been shown to influence these PVN 
a1 receptors, as well as eating Moreover, evidence suggests that this a,- 
receptor system becomes most active and exerts its maximum physiological effects pre- 
cisely at the start of active cycle, when circulating CORT levels normally peak and 
when eating behavior, and in particular carbohydrate preference, is strongest. 1-3 
This report reviews the results of three studies that have used radioligand receptor 
binding techniques to examine the a,-noradrenergic receptors in discrete hypothalamic 
sites, including the PVN, of rats that are: (i) maintained for six weeks on a high-fat 
diet (Purina lab chow mixed with 30% wt/wt Crisco) versus lab chow; (ii) lean (FA/-) 
versus obese (fa/fa) genetically controlled animals of the Zucker strain; and (iii) 
adrenalectomized rats treated with either cholesterol or CORT or sham-operated rats 
treated with cholesterol. 
a Address for correspondence: Dr. M. Jhanwar-Uniyal, Box 278, The Rockefeller University, 
1230 York Avenue, New York, NY 10021. 
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FIGURE 1. [3Hlp-aminoclonidine binding (fmoles/mg protein f SEM) to a,-noradrenergic 
receptors in the paraventricular nucleus (PVN) of rats that became moderate to severely obese 
when kept on high-fat diet (left panel), of lean and genetically controlled obese Zucker rats (middle 
panel), and of rats receiving either SHAM ADX + cholesterol implants (200 mg), ADX + cho- 
lesterol, or ADX + CORT (200 mg) (right panel). * p < 0.05, ** p < 0.01, and *** p < 0.001 
for direct comparisons between groups. 
METHODS 
A standard radioligand binding technique, using the a2-noradrenergic receptor 
agonist ['HI p-aminoclonidine ([3H]PAC; 45.8 Ci/mmol), was employed to determine 
the a2-receptor density in seven micropunched hypothalamic areas. Nonspecific binding 
was determined in the presence of phentolamine, and the results are expressed as 13H]PAC 
specifically bound in fmoles/mg protein. 
RESULTS 
Experiment 1: a' Receptors in Relation to Diet-Induced Obesity 
The exposure to a high-fat diet for six weeks caused variable changes in body weight 
in individual rats, ranging from low to severe levels of obesity. Analyses of hypotha- 
lamic a2 receptors (FIG. 1) indicated a significant increase in [3H]PAC binding in the 
PVN of moderate (+ 50%; p < 0.05) and severely (+ 100%; p < 0.001) dietary-induced 
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obese rats, and also in the dorsomedial nucleus of severely obese rats, as compared 
to dietary-resistant and chow-fed rats (+ 100%; p < 0.01). In contrast, the density of 
a,-noradrenergic receptors in other hypothalamic areas remained ~nchanged .~  
Experiment 2: a, -Noradrenergic Receptors in Genetically Controlled 
Obese and k a n  Zucker Rats 
FIGURE 1 presents the [3]PAC binding results for the PVN of lean and obese Zucker 
rats. As shown here, genetically obese rats had a significantly greater number of avail- 
able a,-noradrenergic receptors in the PVN (+ 120%; p < 0.05) than did their lean 
littermates. Other hypothalamic areas, however, exhibited no group differences in their 
a,-receptor density. 
Experiment 3: a,-Noradrenergic Receptors in Relation to 
Circulating Levels of CORT 
As shown in FIGURE 1, the loss of circulating CORT through adrenalectomy (ADX) 
caused a significant decrement (- 46%; p < 0.05) in [3]PAC binding to al-noradrenergic 
receptors, specifically in the PVN., Subcutaneous CORT implants, which raised cir- 
culating CORT levels to 14 pg%, totally and significantly reversed the [3]PAC binding 
in the PVN (p < 0.001). This down regulation of PVN a, receptors in ADX rats, as- 
sociated with a dramatic decline in eating behavior, was completely reversed by chronic 
subcutaneous CORT implants, which raised circulating hormone levels to 14 pg% and 
significantly increased food intake. The only other hypothalamic area affected was 
the supraoptic nucleus, which exhibited the opposite pattern of changes in az-receptor 
binding. 
CONCLUSION 
The results of these studies demonstrate that the a,-noradrenergic receptors spe- 
cifically in the PVN, which are known to have a role in the control of energy intake 
and expenditure, exhibit dramatic changes in relation to dietary, genetic, and hormonal 
factors that are known to contribute to the onset and maintenance of obesity. Further 
research is needed to establish whether these receptor changes precede or are conse- 
quent to the development of hyperphagia and weight gain. 
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